Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

ESCAPE Study : Validation of a Specific Tool Scoring Residents at Risk of Escaping/Elopement From Nursing Homes (ESCAPE) (ESCAPE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03662464
Recruitment Status : Recruiting
First Posted : September 7, 2018
Last Update Posted : October 4, 2018
Sponsor:
Information provided by (Responsible Party):
Assistance Publique Hopitaux De Marseille

Brief Summary:

Residents' escapes occur even if most of the nursing homes (NH) have set up specific devices to prevent from this risk. Therefore, the need to develop and validate a specific tool to assess the risk of escaping was obvious to the working group, aim at emphasizing patient centered-care by the nurses' staff and help to develop personalized devices.

Aim of the study: develop and validate a specific tool to score the risk of escaping in NH residents Study design: Observational prospective multicentered cohort study Nursing homes volunteer to participate Location: Provence Alpes Cotes d'Azur Region ( South East of France) Population: 4050 NH residents. Duration: two years, each resident included is followed up for one year Measures: Nursing homes characteristics, residents characteristics ( social and from medical record); Escape Scale (25 items with a Yes/no answer; filled up during a nurses staff meeting for each resident and every three months; 3 sub scales: resident environmental items, social items, and medical items.


Condition or disease Intervention/treatment
Elopement or Escaping of Nursing Home Resident With or Without Dementia Other: No intervention

Layout table for study information
Study Type : Observational
Estimated Enrollment : 4050 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: ESCAPE STUDY : A Specific Tool for Detecting Nursing Home Residents (With or Without Dementia) at Risk of Escaping for the Use of Caregivers: Psychometric Properties and Definition of Risk Levels
Estimated Study Start Date : October 2018
Estimated Primary Completion Date : October 2020
Estimated Study Completion Date : April 2021

Resource links provided by the National Library of Medicine



Intervention Details:
  • Other: No intervention
    develop and validate a specific tool to score the risk of escaping in Nursing Homes residents


Primary Outcome Measures :
  1. Escape/elopement occurence [ Time Frame: 2 years ]
    Each Event occurrence is notify by the nurses staff at any time



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Resident of the nursing homes in Provence Alpes Cotes d'Azur Region ( South East of France)
Criteria

Inclusion Criteria:

  • Every resident of Nursing home participating to the study
  • Living in the NH for three months or more
  • With a living prognosis longer than 3 Months

Exclusion Criteria:

  • Prognosis less than three months
  • Bedridden (not able to move alone from bed to chair)
  • Nursing home short stay scheduled < 3 months

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03662464


Contacts
Layout table for location contacts
Contact: Elisabeth POULIN 06 79 72 41 09 elisabeth.poulin@ap-hm.fr
Contact: Sylvie Bonin-Guillaume 003391744612 Sylvie.BONIN@ap-hm.fr

Locations
Layout table for location information
France
Direction Recherche clinique et Innovation Recruiting
Marseille, Paca, France, 13354
Contact: Kahena AMICHI       drci@ap-hm.fr   
Sponsors and Collaborators
Assistance Publique Hopitaux De Marseille
Investigators
Layout table for investigator information
Study Director: Jean-Olivier ARNAUD Assitance Publique des Hopitaux de Marseille
Layout table for additonal information
Responsible Party: Assistance Publique Hopitaux De Marseille
ClinicalTrials.gov Identifier: NCT03662464    
Other Study ID Numbers: 2016-55
IDRCB ( Other Identifier: 2017-A02827-46 )
First Posted: September 7, 2018    Key Record Dates
Last Update Posted: October 4, 2018
Last Verified: January 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Dementia
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurocognitive Disorders
Mental Disorders